CapEx at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s capex?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported capex of $3.85M in Q1 2026.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s capex?
- Over 3 years (2021 to 2024), Madrigal Pharmaceuticals, Inc.'s capex has grown at a 91.2% compound annual growth rate (CAGR), from $209K to $1.46M.
- What does capex mean?
- Cash spent on physical assets like equipment or facilities.
- How do you interpret capex?
- Higher spending indicates investment in physical capacity, while lower spending suggests a focus on asset-light operations.
- How does capex compare across companies?
- Standard metric for assessing physical infrastructure investment across all sectors.